Ssali Agnes, Nunn Andrew, Mbonye Martin, Anywaine Zacchaeus, Seeley Janet
Medical Research Council/UVRI Uganda Research Unit on AIDS, Uganda.
Medical Research Council Clinical Trials Unit at University College, London, UK.
Contemp Clin Trials Commun. 2017 May 17;7:44-47. doi: 10.1016/j.conctc.2017.05.007. eCollection 2017 Sep.
The reasons why research participants join clinical trials remains an area of inquiry especially in low and middle income countries.
We conducted exit interviews with participants who took part in a trial which aimed to evaluate whether long term prophylaxis with cotrimoxazole can be safely discontinued among adults who have been stabilised on antiretroviral therapy (ART). Participants were all reported to be stable on ART and had been participating in the trial for between 12 and 36 months; at the end of the trial participants were interviewed using a semi-structured questionnaire. One of the objectives of the exit interview was to find out what motivated the participants to join the research.
Participants gave personal reasons for joining the trial, frequently linked to their health and well-being as well as reduction of pill burden.
We conclude that underlying reasons for joining clinical trials may extend beyond or can be different from the rationale given to the participants before enrolment by the research team. The reasons that motivate enrolment to clinical trials and research in general require further investigation in different settings.
ISRCTN44723643.
研究参与者参加临床试验的原因仍是一个研究领域,在低收入和中等收入国家尤其如此。
我们对参加一项试验的参与者进行了退出访谈,该试验旨在评估在接受抗逆转录病毒治疗(ART)病情已稳定的成年人中,是否可以安全停用复方新诺明长期预防用药。据报告,所有参与者接受ART治疗病情均稳定,且已参与该试验12至36个月;在试验结束时,使用半结构化问卷对参与者进行访谈。退出访谈的目标之一是了解促使参与者参加该研究的因素。
参与者给出了参加试验的个人原因,这些原因通常与他们的健康和幸福以及减少服药负担有关。
我们得出结论,参加临床试验的潜在原因可能超出研究团队在入组前向参与者说明的理由,或者与之不同。促使人们参加临床试验及一般研究的原因需要在不同环境中进一步调查。
ISRCTN44723643。